The co-detected additional mutations identified using the Melacarta Sequenom panel included six melanomas containing NRAS together with EPHB6G404S mutation, and six melanomas containing NRAS together with METT992I mutation (Table 3). The gene discussed is NRAS; the disease is melanoma.